Evidence map›Paper›PMID 28264930›Full record

ReviewThe Journal of biological chemistry2017

Non-enzymatic molecular damage as a prototypic driver of aging.

Alexey Golubev, Andrew D Hanson, Vadim N Gladyshev

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Metabolomic Profiling ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Stability of enzyme immobilized on the nanofluidic channel surface.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Article
  13. Article
  14. Article
  15. Epigenetics, DNA damage, and aging.The Journal of clinical investigation · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Molecular Damage in Aging.Nature aging · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexey GolubevFrom the Department of Biochemistry, Saint-Petersburg State University, Saint Petersburg 199034, Russia, aeeouelxglbv@gmail.com.
Andrew D Hansonthe Horticultural Sciences Department, University of Florida, Gainesville, Florida 32611, and adha@ufl.edu.
Vadim N Gladyshevthe Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115 vgladyshev@rics.bwh.harvard.edu.

Funding

Methionine sulfoxide reduction, selenium and agingR01AG021518 · NIA · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2003 to 2018
$5.0M
Mechanisms of lifespan controlDP1AG047745 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2013 to 2018
$4.4M
IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
NIA NIH HHS DP1 AG047745NIA NIH HHS R01 AG021518NIGMS NIH HHS R01 GM061603NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

The chemical potentialities of metabolites far exceed metabolic requirements. The required potentialities are realized mostly through enzymatic catalysis. The rest are realized spontaneously through organic reactions that (i) occur wherever appropriate reactants come together, (ii) are so typical that many have proper names (

Indexed as

AgingAnimalsHumansOxidation-ReductionReactive Oxygen SpeciesReactive Oxygen Speciesagingdamageenzymeenzyme mechanismmechanismmetabolismmetabolitemetabolite damageside-productside reactionspontaneous chemistrysubstrate specificity

Identifiers

PMID28264930
PMCPMC5391736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.